EU Approves Bayer's Eylea 8 Mg For Extended 6-Month Dosing In Retinal Diseases
27/6 09:07
(RTTNews) - Bayer (BAYZF.PK, BAYRY.PK, BYR.L), a German pharmaceutical and life sciences major, announced that the European Commission has granted a label extension in the European Union for Eylea 8 mg (aflibercept 8 mg, 114.3 mg/ml solution for injection) with extended treatmen...